Age-matched Reference Values for Circulating Natural Killer T-like Cells
NCT ID: NCT06450743
Last Updated: 2024-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-05-03
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation
NCT02978274
The Role of NK Cells to Detect Blood Infection in ALL.
NCT06160115
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
NCT02562963
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036
A Long Term Follow-up Study of TScan TCR-T Products
NCT06976736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Derivation Cohort
Adult and pediatric patients who have routinely performed the lymphocyte immunophenotyping test, including also the enumeration of NKT-like cells, to exclude an immunological impairment during the period from May 2019 to March 2020 (for adults) and from May 2019 to August 2021 (for pediatric patients).
Lymphocyte Immunophenotyping Test
Absolute enumeration of peripheral blood lymphocyte subpopulations
Validation Cohort
Healthy adult blood donors in order to validate the obtained results.
Lymphocyte Immunophenotyping Test
Absolute enumeration of peripheral blood lymphocyte subpopulations
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lymphocyte Immunophenotyping Test
Absolute enumeration of peripheral blood lymphocyte subpopulations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* without acute or chronic pathological conditions
* matched for sex and age with the retrospective adult derivation cohort
Exclusion Criteria
* one of the lymphocyte subpopulations tested out of range
* undergoing surgery or dentistry intervention in the past two months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Trombetta, BSc
Role: PRINCIPAL_INVESTIGATOR
Flow Cytometry Laboratory, Clinical Pathology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, MI, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0014476
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.